Tech

Europe’s first hallucinogen clinical trial office opens in London

Europe’s first commercial facility for hallucinogen testing held in London, aims to make the UK a global leader in psychedelic research and innovation. From the report: British startup Clerkenwell Health aims to start clinical trials at its central London facility in August, initially focusing on the use of psilocybin to help people deal with the anxiety associated with diagnosing a terminal illness and support their end of life. It’s focused. Care. The news comes as scientists and policy makers gather in London this Wednesday for the Agenda for Psych Symposium, a full-day program where scientists and policy makers discuss the latest research and futures of Europe’s hallucinogen industry.

Europe’s first hallucinogen clinical trial office opens in London

Source link Europe’s first hallucinogen clinical trial office opens in London

Back to top button